CN Stock MarketDetailed Quotes

301096 Hangzhou Bio-Sincerity Pharma-Tech

Watchlist

41.17
+0.13+0.32%

Market Closed Nov 8 15:00 CST

4.50BMarket Cap21.20P/E (TTM)

Hangzhou Bio-Sincerity Pharma-Tech Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hangzhou Bio-Sincerity Pharma-Tech Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/FY	-- / 1.687B	--
--	2024/FY	-- / 1.315B	--
--	2023/FY	1.017B / 922.000M	--
--	2022/FY	607.411M / 622.000M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/FY-- / 1.687B--

--2024/FY-- / 1.315B--

--2023/FY1.017B / 922.000M--

--2022/FY607.411M / 622.000M--

--------

Unlock Free Earnings Estimates

Open Account

Hangzhou Bio-Sincerity Pharma-Tech Earnings Reports

Baicheng Pharmaceutical: Report for the third quarter of 2024

Oct 28 12:00 ET

Hangzhou Bio-Sincerity Pharma-Tech: Summary of Half-Year Report in 2024.

Aug 14 12:00 ET

Hangzhou Bio-Sincerity Pharma-Tech: Half-year report for the year 2024.

Aug 14 12:00 ET

Baicheng Pharmaceutical: Report for the first quarter of 2024

Apr 22 12:00 ET

Analyst Rating

Updated: Nov 9, 2024

Strong Buy

Strong Buy
72.22%
Buy
27.78%
Hold
0.00%
Underperform
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall